Key facts
- Dimer Instruments’s last known valuation is $26.0M (Jul 2025).
- It has raised $6.5M across 1 recorded rounds; the latest was Early Stage VC ($6.5M) in Apr 2024.
- Dimer Instruments has filed 2 Form Ds with the SEC since 2024, most recently Jul 2025 ($6.5M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Dimer Instruments
Funding rounds
1 roundsAbout Dimer Instruments
Manufacturer of real-time analytical instruments designed for monitoring and optimizing pharmaceutical manufacturing processes. The company offers systems that capture continuous process data, monitor critical quality attributes, enable immediate process adjustments, and include software for advanced data management, regulatory-compliant recordkeeping, and historical data analysis, enabling pharmaceutical manufacturers to improve process control, enhance product consistency, and data-driven development of protein-based therapies.
- Sector
- Healthcare
- HQ
- Santa Barbara, CA, United States
- Founded
- 2023
- Employees
- 12
- Website
- dimerinstruments.com/
- Ownership
- Privately Held (backing)
Dimer Instruments doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dimer Instruments shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dimer Instruments in its N-PORT filings yet. We sweep new filings monthly.